Travere Therapeutics Inc (NASDAQ:TVTX)

Delayed Data
As of 4:00pm ET
 -0.24 / -0.95%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Travere Therapeutics Inc have a median target of 42.00, with a high estimate of 49.00 and a low estimate of 24.00. The median estimate represents a +68.61% increase from the last price of 24.91.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Travere Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 23.52%
Growthannually -27.80%


Growthquarterly 6.46%
Growthannually -8.09%
Key to the earnings and sales forecast charts.